https://investor.ironwoodpharma.com/press-releases/press-release-details/2009/Ironwood-and-Forest-Announce-Positive-Linaclotide-Results-from-Two-Pivotal-Phase-3-Trials-In-Patients-with-Chronic-Constipation/default.aspx
Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.
- November 2, 2009